RESI Boston 2017

Fairbanks Pharma CEO Alan Schneyer at RESI Boston
Fairbanks CEO Alan Schneyer at RESI Boston 2017

Fairbanks Pharmaceuticals was selected as a finalist to compete in the RESI Boston 2017 Innovation Challenge. On September 26, Fairbanks Co-Founder and CEO Alan Schneyer presented a poster at RESI, met with potential investors and funding agencies, and networked with angel investors.

The response so far has been very encouraging and has led to a number of follow up conversations.